BCYC vs EW · rev $35.3M vs P/E 47, rev $3.39B
Bicycle Therapeutics Ltd (BCYC) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported BCYC revenue for 2024-12-31 was $35.3M. Net income was -$169.0M. Revenue was up 30.8% from 2023-12-31 to 2024-12-31. BCYC currently screens at market cap $554.0M.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BCYC currently screens at market cap $554.0M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BCYC and EW stock pages for the full models.
Not investment advice.